Analytical Data
-
Gene name
RASL11A
- Application
-
Alternative Names
Ras-like protein family member 11A; RAS-like. family 11. member A; Rasl11a; RSLBA_HUMAN
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6T310
-
Expression Region
1-242 aa
-
AA Sequence
MRPLSMSGHF LLAPIPESSS DYLLPKDIKL AVLGAGRVGK SAMIVRFLTK RFIGDYEPNT GKLYSRLVYV EGDQLSLQIQ DTPGGVQIQD SLPQVVDSLS KCVQWAEGFL LVYSITDYDS YLSIRPLYQH IRKVHPDSKA PVIIVGNKGD LLHARQVQTQ DGIQLANELG SLFLEISTSE NYEDVCDVFQ HLCKEVSKMH GLSGERRRAS IIPRPRSPNM QDLKRRFKQA LSPKVKAPSA LG
-
Molecular Weight
27.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RASL11A, a member of the RAS superfamily of small GTPases, has garnered attention due to its potential roles in cellular signaling, proliferation, and differentiation processes. As a recently identified protein, it displays unique structural and functional characteristics that distinguish it from other RAS family members. Initial studies suggest that RASL11A may play significant roles in various biological processes, including cell cycle regulation and oncogenesis, making it a candidate of interest in cancer research. Researchers are particularly focused on understanding its mechanisms of action and interactions with downstream effectors, as this knowledge could lead to novel therapeutic strategies for targeting Ras-related signaling pathways in diseases. The development of recombinant RASL11A protein has enabled scientists to investigate its properties in vitro, providing insights into its biochemical functions and potential implications in cell biology. Given the growing evidence linking RAS proteins to tumorigenesis and their challenging nature as drug targets, RASL11A represents a promising area for exploration in both fundamental research and clinical applications aimed at understanding and combating cancer.
